PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-21.67%
Both yoy net incomes decline, with CX at -53.70%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-27.31%
Negative yoy D&A while CX is 1.43%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-100.00%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
8.62%
SBC growth of 8.62% while CX is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
223.47%
Well above CX's 367.36% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
100.00%
AR growth well above CX's 187.63%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-59.74%
Negative yoy inventory while CX is 1810.95%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-100.00%
Both negative yoy AP, with CX at -123.42%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
100.00%
Some yoy usage while CX is negative at -260.88%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-3.21%
Both negative yoy, with CX at -43.87%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
20.40%
Operating cash flow growth below 50% of CX's 42.96%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-19.13%
Both yoy lines negative, with CX at -10.58%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-285.45%
Negative yoy acquisition while CX stands at 574.07%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
150.83%
Purchases well above CX's 7.45%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
No Data
No Data available this quarter, please select a different quarter.
-121.19%
Both yoy lines negative, with CX at -10.18%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-79.35%
We reduce yoy invests while CX stands at 12.78%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
1403.85%
Debt repayment above 1.5x CX's 47.91%, indicating stronger deleveraging. David Dodd would verify if expansions are not neglected.
No Data
No Data available this quarter, please select a different quarter.
-97.76%
We cut yoy buybacks while CX is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.